The opening of a new stem cell research laboratory on the fifth floor of Lifespan’s Coro Building in the Knowledge District affirms the city’s place as a budding academic clinical-research hub, according to Dr. Peter Quesenberry, director of hematology oncology at Rhode Island Hospital and The Miriam Hospital. more

PROVIDENCE – Rhode Island Hospital is taking part in a multisite clinical trial to measure the efficacy of a catheter-based treatment for uncontrolled hypertension. The principal investigator is Dr. Timothy P. Murphy, interventional radiologist and director of the Vascular Disease Research Center. more

PROVIDENCE – A new study by The Miriam Hospital researcher Robyn L. Fielder published online by the Journal of Adolescent Health has found that romantic encounters are the most common sexual behavior among women in their first year of college. more

A group of human resource executives from five Massachusetts biotechnology companies gathered Tuesday to brainstorm how to better prepare military veterans for jobs in the sector, according to the Boston Business Journal. more

PROVIDENCE – A five-year, $8.5 million National Institutes of Health grant will continue support for the Lifespan/Tufts/Brown Center for AIDS Research (CFAR) through The Miriam Hospital, its primary contracting institution. more

Dupuis Oil has announced it will partner with the Rhode Island chapter of the National Multiple Sclerosis Society by contributing donations to the society and discounts to customers. more

BOSTON – The Boston Foundation released a report showing that Gov. Deval L. Patrick’s administration’s investments in the life sciences sector are making a “measurable impact on job creation and spurring economic growth” throughout Massachusetts. more

Eily Cournoyer has quite the story to tell. more

WOONSOCKET – The CVS Caremark Charitable Trust announced last week that it has given $2.6 million in grants to 66 nonprofit organizations across the United States. more

The unique technology of Providence-based Nabsys Inc., a life sciences company focused on technology for analyzing DNA, has garnered industry attention nationally. The company recently closed a $20 million financing round. Dr. Barrett Bready, president, CEO and a Rhode Island-native, discusses his company’s recent success, its unique technology and the future of the state’s biotech industry. more